Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christopher J Sweeney, M.B.,B.S.

Co-Author

This page shows the publications co-authored by Christopher Sweeney and Katherine Morel.
Connection Strength

1.780
  1. NF-?B Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR Variants. Mol Cancer Res. 2021 07; 19(7):1137-1145.
    View in: PubMed
    Score: 0.957
  2. EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer. Nat Cancer. 2021 Apr; 2(4):444-456.
    View in: PubMed
    Score: 0.238
  3. DMAPT is an Effective Radioprotector from Long-Term Radiation-Induced Damage to Normal Mouse Tissues In Vivo. Radiat Res. 2019 08; 192(2):231-239.
    View in: PubMed
    Score: 0.209
  4. Chronic low dose ethanol induces an aggressive metastatic phenotype in TRAMP mice, which is counteracted by parthenolide. Clin Exp Metastasis. 2018 10; 35(7):649-661.
    View in: PubMed
    Score: 0.197
  5. Parthenolide Selectively Sensitizes Prostate Tumor Tissue to Radiotherapy while Protecting Healthy Tissues In Vivo. Radiat Res. 2017 05; 187(5):501-512.
    View in: PubMed
    Score: 0.180
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.